.jpg "Magdalena Kasendra, PhD photo")
Director of Research and Development
Center for Stem Cell and Organoid Medicine (CuSTOM) Accelerator Cincinnati Children’s Hospital Medical Center, Ohio, United States
Magdalena Kasendra is the Director of Research and Development of CuSTOM (Center for Stem Cell & Organoid Medicine) Accelerator. She leads a multifaceted effort to translate breakthrough discoveries in stem cell biology and organ development into innovative organoid-based solutions to address unmet medical needs. These include organoid-based platforms enabling discovery and development of safer and more efficient drugs, precision medicine applications and organoid-based therapies for end-stage diseases.
Dr. Kasendra’s career spans industry, academia and the start-up world. Prior to joining CuSTOM’s leadership team, she managed the multidisciplinary team responsible for developing, translating and commercializing Organs-on-Chips technology at Emulate Inc., a spin-off from Harvard's Wyss Institute for Biologically Inspired Engineering. This research has led to major advances in bioengineering of intestinal tissue by combining microchip manufacturing methods and organoid technology and demonstrated the utility of this platform in drug development, disease modeling and precision medicine. She performed her PhD project at Novartis Vaccines and Development, which was followed by several post-doctoral research fellowship at the Harvard Medical School and the Wyss Institute for Biologically Inspired Engineering at Harvard University. She has authored numerous publications and patents.
Disclosure information not submitted.
Tuesday, February 8, 2022
11:30 AM – 1:00 PM